<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">RNA</journal-id>
<journal-id journal-id-type="iso-abbrev">RNA</journal-id>
<journal-id journal-id-type="publisher-id">RNA</journal-id>
<journal-title-group>
<journal-title>RNA</journal-title>
</journal-title-group>
<issn pub-type="ppub">1355-8382</issn>
<issn pub-type="epub">1469-9001</issn>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27530828</article-id>
<article-id pub-id-type="pmc">4986885</article-id>
<article-id pub-id-type="medline">9509184</article-id>
<article-id pub-id-type="doi">10.1261/rna.057919.116</article-id>
<article-id pub-id-type="publisher-id">RA</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Splicing-factor alterations in cancers</article-title>
<alt-title alt-title-type="left-running">Anczuków and Krainer</alt-title>
<alt-title alt-title-type="right-running">Splicing-factor alterations in cancers</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Anczuków</surname>
<given-names>Olga</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Krainer</surname>
<given-names>Adrian R.</given-names>
</name>
</contrib>
</contrib-group>
<aff>Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA</aff>
<author-notes>
<fn fn-type="present-address" id="FN1">
<label>1</label>
<p>Present address: The Jackson Laboratory for Genomic Medicine, Farmington, CT 06032, USA</p>
</fn>
<corresp>Corresponding authors: <email>olga.anczukow@jax.org</email>, <email>krainer@cshl.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>9</month>
<year>2016</year>
</pub-date>
<volume>22</volume>
<issue>9</issue>
<fpage>1285</fpage>
<lpage>1301</lpage>
<permissions>
<copyright-statement>
<ext-link ext-link-type="uri" xlink:href="http://www.rnajournal.org/site/misc/terms.xhtml">© 2016 Anczuków and Krainer; Published by Cold Spring Harbor Laboratory Press for the RNA Society</ext-link>
</copyright-statement>
<copyright-year>2016</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
<license-p>This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see <ext-link ext-link-type="uri" xlink:href="http://rnajournal.cshlp.org/site/misc/terms.xhtml">http://rnajournal.cshlp.org/site/misc/terms.xhtml</ext-link>). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="1285.pdf"></self-uri>
<abstract>
<p>Tumor-associated alterations in RNA splicing result either from mutations in splicing-regulatory elements or changes in components of the splicing machinery. This review summarizes our current understanding of the role of splicing-factor alterations in human cancers. We describe splicing-factor alterations detected in human tumors and the resulting changes in splicing, highlighting cell-type-specific similarities and differences. We review the mechanisms of splicing-factor regulation in normal and cancer cells. Finally, we summarize recent efforts to develop novel cancer therapies, based on targeting either the oncogenic splicing events or their upstream splicing regulators.</p>
</abstract>
<funding-group>
<award-group id="funding-1">
<funding-source>National Cancer Institute <named-content content-type="funder-id">http://dx.doi.org/10.13039/100000054</named-content></funding-source>
<award-id>CA13106</award-id>
<award-id>K99CA178206</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>